Pliant Therapeutics
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $4,839 |
Gross Profit | -622 | -513 | 4,375 | |
EBITDA | -56,354 | -54,364 | -45,997 | -40,324 |
EBIT | -56,886 | -54,986 | -46,510 | -40,788 |
Net Income | -57,763 | -55,854 | -46,955 | -41,109 |
Net Change In Cash | 0 | 0 | 0 | 4,839 |
Free Cash Flow | -33,169 | -46,548 | -31,763 | -25,163 |
Cash | 79,616 | 80,386 | 114,297 | 63,234 |
Basic Shares | 60,730 | 60,382 | 60,180 | 59,904 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $1,580 | $9,685 | $7,572 | $41,817 |
Gross Profit | 1,580 | 6,004 | 7,572 | 41,817 |
EBITDA | -158,228 | -118,849 | -18,451 | -40,335 |
EBIT | -160,069 | -122,530 | -19,986 | -41,645 |
Net Income | -161,336 | -121,498 | -17,907 | -39,745 |
Net Change In Cash | 1,580 | 9,685 | 7,572 | 41,817 |
Cost of Revenue | -17,981 | 783 | -34,925 | |
Free Cash Flow | -117,282 | -96,391 | -77,396 | -38,803 |
Cash | 63,234 | 33,685 | 51,665 | 50,882 |
Basic Shares | 58,719 | 42,015 | 35,846 | 35,552 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.95 |
2024-06-30 | -$0.92 |
2024-03-31 | -$0.78 |
2023-12-31 | -$0.69 |
